Michael Allon1, Silvio H Litovsky2, Yingying Zhang3, Ha Le4, Alfred K Cheung4,5,6, Yan-Ting Shiu7. 1. Division of Nephrology, Department of Medicine and. 2. Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama. 3. Divisions of Epidemiology and. 4. Nephrology and Hypertension, Department of Internal Medicine, University of Utah, Salt Lake City, Utah. 5. Medical Service, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah; and. 6. Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. 7. Nephrology and Hypertension, Department of Internal Medicine, University of Utah, Salt Lake City, Utah; y.shiu@hsc.utah.edu.
Abstract
BACKGROUND AND OBJECTIVES: Preoperative arterial function is associated with arteriovenous fistula (AVF) development. Because arterial pathology may correlate with its function, preexisting arterial intimal hyperplasia may be associated with AVF development. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Vascular specimens obtained from 125 patients (with minimal 2 mm arterial diameter and 2.5 mm venous diameter) undergoing AVF creation were quantified for arterial intimal hyperplasia, arterial medial fibrosis, arterial microcalcification, and venous intimal hyperplasia. A 6-week postoperative ultrasound quantified AVF diameter, blood flow, and stenosis. Clinical AVF maturation was assessed using a predefined protocol. In a prospective cohort study design, we investigated the association of preexisting arterial intimal hyperplasia with the postoperative AVF diameter, blood flow, stenosis, and clinical maturation failure, after controlling for baseline demographics, comorbidities, and preoperative vein diameter. Additional analyses evaluated whether other vascular pathologies interacted with arterial intimal hyperplasia in affecting AVF outcomes. RESULTS: The median intimal thickness of the native artery was 22.0 μm (interquartile range, 14.8-37.1 μm). The median postoperative AVF diameter was 4.8 (interquartile range, 3.7-6.8) mm, blood flow was 796 (interquartile range, 413-1036) ml/min, and stenosis was present in 37 out of 98 patients with ultrasound data (38%). AVF nonmaturation occurred in 37 out of 125 patients (30%). Preexisting arterial intimal thickness was not significantly associated with AVF blood flow (-12 ml/min; 95% confidence interval [95% CI], -55 to 30 ml/min), diameter (-0.04 mm; 95% CI, -0.21 to 0.14 mm), stenosis (odds ratio, 0.93; 95% CI, 0.75 to 1.14), or clinical maturation failure (odds ratio, 1.07; 95% CI, 0.90 to 1.28), all per 10 μm increase. There was no significant interaction of preexisting arterial intimal thickness and postoperative AVF outcomes with arterial medial fibrosis, arterial microcalcification, or venous intimal hyperplasia. CONCLUSIONS: Preexisting arterial intimal hyperplasia is not associated with the 6-week AVF blood flow, diameter or stenosis, or clinical maturation when the preoperative arterial diameter is ≥2 mm.
BACKGROUND AND OBJECTIVES: Preoperative arterial function is associated with arteriovenous fistula (AVF) development. Because arterial pathology may correlate with its function, preexisting arterial intimal hyperplasia may be associated with AVF development. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Vascular specimens obtained from 125 patients (with minimal 2 mm arterial diameter and 2.5 mm venous diameter) undergoing AVF creation were quantified for arterial intimal hyperplasia, arterial medial fibrosis, arterial microcalcification, and venous intimal hyperplasia. A 6-week postoperative ultrasound quantified AVF diameter, blood flow, and stenosis. Clinical AVF maturation was assessed using a predefined protocol. In a prospective cohort study design, we investigated the association of preexisting arterial intimal hyperplasia with the postoperative AVF diameter, blood flow, stenosis, and clinical maturation failure, after controlling for baseline demographics, comorbidities, and preoperative vein diameter. Additional analyses evaluated whether other vascular pathologies interacted with arterial intimal hyperplasia in affecting AVF outcomes. RESULTS: The median intimal thickness of the native artery was 22.0 μm (interquartile range, 14.8-37.1 μm). The median postoperative AVF diameter was 4.8 (interquartile range, 3.7-6.8) mm, blood flow was 796 (interquartile range, 413-1036) ml/min, and stenosis was present in 37 out of 98 patients with ultrasound data (38%). AVF nonmaturation occurred in 37 out of 125 patients (30%). Preexisting arterial intimal thickness was not significantly associated with AVF blood flow (-12 ml/min; 95% confidence interval [95% CI], -55 to 30 ml/min), diameter (-0.04 mm; 95% CI, -0.21 to 0.14 mm), stenosis (odds ratio, 0.93; 95% CI, 0.75 to 1.14), or clinical maturation failure (odds ratio, 1.07; 95% CI, 0.90 to 1.28), all per 10 μm increase. There was no significant interaction of preexisting arterial intimal thickness and postoperative AVF outcomes with arterial medial fibrosis, arterial microcalcification, or venous intimal hyperplasia. CONCLUSIONS: Preexisting arterial intimal hyperplasia is not associated with the 6-week AVF blood flow, diameter or stenosis, or clinical maturation when the preoperative arterial diameter is ≥2 mm.
Authors: Walter Osika; Frida Dangardt; Julia Grönros; Ulf Lundstam; Anna Myredal; Mats Johansson; Reinhard Volkmann; Tomas Gustavsson; Li Ming Gan; Peter Friberg Journal: Arterioscler Thromb Vasc Biol Date: 2006-12-28 Impact factor: 8.311
Authors: Michelle L Robbin; Tom Greene; Alfred K Cheung; Michael Allon; Scott A Berceli; James S Kaufman; Matthew Allen; Peter B Imrey; Milena K Radeva; Yan-Ting Shiu; Heidi R Umphrey; Carlton J Young Journal: Radiology Date: 2015-12-22 Impact factor: 11.105
Authors: Michael Allon; Silvio Litovsky; Carlton J Young; Mark H Deierhoi; Jeremy Goodman; Michael Hanaway; Mark E Lockhart; Michelle L Robbin Journal: Am J Kidney Dis Date: 2011-06-30 Impact factor: 8.860
Authors: M Allon; M E Lockhart; R Z Lilly; M H Gallichio; C J Young; J Barker; M H Deierhoi; M L Robbin Journal: Kidney Int Date: 2001-11 Impact factor: 10.612
Authors: R Kornowski; G S Mintz; K M Kent; A D Pichard; L F Satler; T A Bucher; M K Hong; J J Popma; M B Leon Journal: Circulation Date: 1997-03-18 Impact factor: 29.690
Authors: Alexandre Abizaid; Marco A Costa; Didier Blanchard; Mariano Albertal; Hélèn Eltchaninoff; Giulio Guagliumi; Laarman Geert-Jan; Andrea S Abizaid; Amanda G M R Sousa; Egon Wuelfert; Lindeboom Wietze; J Eduardo Sousa; Patrick W Serruys; Marie-Claude Morice Journal: Eur Heart J Date: 2004-01 Impact factor: 29.983
Authors: Ivan D Maya; Jeremy C O'Neal; Carlton J Young; Jill Barker-Finkel; Michael Allon Journal: Clin J Am Soc Nephrol Date: 2008-10-22 Impact factor: 8.237
Authors: Yingnan Li; Yong He; Isabelle Falzon; Brayden Fairbourn; Spencer Tingey; Peter B Imrey; Milena K Radeva; Gerald J Beck; Jennifer J Gassman; Prabir Roy-Chaudhury; Scott A Berceli; Alfred K Cheung; Yan-Ting Shiu Journal: Kidney Int Rep Date: 2022-05-21